Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Sex-specific Difference for Small Cell Lung Cancer from Immunotherapy Advancement
You Mo; Yiwei Qin; Jian Shangguan; Duncan Wei; Meng Wu; Dawei Chen; Jinming Yu;
Arch Bronconeumol. 2024;60 Supl 2:S13-21
Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung Adenocarcinoma
Álvaro Taus; Laura Camacho; Pedro Rocha; Ainhoa Hernández; Raquel Longarón; Sergi Clavé; Lierni Fernández-Ibarrondo; Marta Salido; Max Hardy-Werbin; Concepción Fernández-Rodríguez; Joan Albanell; Beatriz Bellosillo; Edurne Arriola;
Arch Bronconeumol. 2021;57:323-9
PD-1 Inhibitor for a Non-Small-Cell Lung Cancer Patient With Paraneoplastic Nephropathy
Hironori Yoshida; Shigeaki Iwatsubo; Takashi Nishimura;
Arch Bronconeumol. 2021;57:311-2